These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 20153576)

  • 41. The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties.
    Bertolotti A; Bell B; Tora L
    Oncogene; 1999 Dec; 18(56):8000-10. PubMed ID: 10637511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ewing's sarcoma fusion protein, EWS/Fli-1 and Fli-1 protein induce PLD2 but not PLD1 gene expression by binding to an ETS domain of 5' promoter.
    Kikuchi R; Murakami M; Sobue S; Iwasaki T; Hagiwara K; Takagi A; Kojima T; Asano H; Suzuki M; Banno Y; Nozawa Y; Murate T
    Oncogene; 2007 Mar; 26(12):1802-10. PubMed ID: 16964281
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activity.
    Jaishankar S; Zhang J; Roussel MF; Baker SJ
    Oncogene; 1999 Sep; 18(40):5592-7. PubMed ID: 10523836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adenovirus 5 early region 1A does not induce expression of the ewing sarcoma fusion product EWS-FLI1 in breast and ovarian cancer cell lines.
    Meric F; Liao Y; Lee WP; Pollock RE; Hung MC
    Clin Cancer Res; 2000 Oct; 6(10):3832-6. PubMed ID: 11051226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1.
    Giorgi C; Boro A; Rechfeld F; Lopez-Garcia LA; Gierisch ME; Schäfer BW; Niggli FK
    Oncotarget; 2015 Oct; 6(30):28895-910. PubMed ID: 26336820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adenovirus E1A does not induce the Ewing tumor-associated gene fusion EWS-FLI1.
    Kovar H; Fallaux FJ; Pribill I; Jugovic D; Bartl S; Ambros PF; Aryee DN; Wiegant JC; Hoeben RC
    Cancer Res; 2000 Mar; 60(6):1557-60. PubMed ID: 10749123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transactivation of cyclin E gene by EWS-Fli1 and antitumor effects of cyclin dependent kinase inhibitor on Ewing's family tumor cells.
    Li X; Tanaka K; Nakatani F; Matsunobu T; Sakimura R; Hanada M; Okada T; Nakamura T; Iwamoto Y
    Int J Cancer; 2005 Sep; 116(3):385-94. PubMed ID: 15818598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors.
    Mendiola M; Carrillo J; García E; Lalli E; Hernández T; de Alava E; Tirode F; Delattre O; García-Miguel P; López-Barea F; Pestaña A; Alonso J
    Int J Cancer; 2006 Mar; 118(6):1381-9. PubMed ID: 16206264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma.
    Ban J; Bennani-Baiti IM; Kauer M; Schaefer KL; Poremba C; Jug G; Schwentner R; Smrzka O; Muehlbacher K; Aryee DN; Kovar H
    Cancer Res; 2008 Sep; 68(17):7100-9. PubMed ID: 18757425
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Participation of nuclear localization signal 2 in the 3'-ETS domain of FLI1 in nuclear translocation of various chimeric EWS-FLI1 oncoproteins in Ewing tumor.
    Honsei N; Ikuta T; Kawana K; Kaneko Y; Kawajiri K
    Int J Oncol; 2006 Sep; 29(3):689-93. PubMed ID: 16865286
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines.
    Szuhai K; Ijszenga M; Tanke HJ; Rosenberg C; Hogendoorn PC
    Cancer Genet Cytogenet; 2006 Apr; 166(2):173-9. PubMed ID: 16631476
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing's sarcoma cells.
    Yang L; Hu HM; Zielinska-Kwiatkowska A; Chansky HA
    Biochem Biophys Res Commun; 2010 Nov; 402(1):129-34. PubMed ID: 20933505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cryptic exons as a source of increased diversity of Ewing tumor-associated EWS-FLI1 chimeric products.
    Kovar H; Jugovic D; Melot T; Zoubek A; Lenoir G; Fink FM; Philip I; Turc-Carel C; Thomas G; Zucman-Rossi J
    Genomics; 1999 Sep; 60(3):371-4. PubMed ID: 10493837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Single-chain antibodies to the EWS NH(2) terminus structurally discriminate between intact and chimeric EWS in Ewing's sarcoma and interfere with the transcriptional activity of EWS in vivo.
    Aryee DN; Kreppel M; Bachmaier R; Uren A; Muehlbacher K; Wagner S; Breiteneder H; Ban J; Toretsky JA; Kovar H
    Cancer Res; 2006 Oct; 66(20):9862-9. PubMed ID: 17047047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene.
    Im YH; Kim HT; Lee C; Poulin D; Welford S; Sorensen PH; Denny CT; Kim SJ
    Cancer Res; 2000 Mar; 60(6):1536-40. PubMed ID: 10749119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma.
    Hu-Lieskovan S; Heidel JD; Bartlett DW; Davis ME; Triche TJ
    Cancer Res; 2005 Oct; 65(19):8984-92. PubMed ID: 16204072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of an inhibitor of the EWS-FLI1 oncogenic transcription factor by high-throughput screening.
    Grohar PJ; Woldemichael GM; Griffin LB; Mendoza A; Chen QR; Yeung C; Currier DG; Davis S; Khanna C; Khan J; McMahon JB; Helman LJ
    J Natl Cancer Inst; 2011 Jun; 103(12):962-78. PubMed ID: 21653923
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts.
    Lessnick SL; Dacwag CS; Golub TR
    Cancer Cell; 2002 May; 1(4):393-401. PubMed ID: 12086853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of p21WAF1/CIP1 as a direct target of EWS-Fli1 oncogenic fusion protein.
    Nakatani F; Tanaka K; Sakimura R; Matsumoto Y; Matsunobu T; Li X; Hanada M; Okada T; Iwamoto Y
    J Biol Chem; 2003 Apr; 278(17):15105-15. PubMed ID: 12560328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A.
    Toretsky JA; Erkizan V; Levenson A; Abaan OD; Parvin JD; Cripe TP; Rice AM; Lee SB; Uren A
    Cancer Res; 2006 Jun; 66(11):5574-81. PubMed ID: 16740692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.